References
Al-Salameh A, Francois P, Giraud S (2010) Intracranial ependymoma associated with multiple endocrine neoplasia type 1. J Endocrinol Invest 33:353–356
Funayama T, Sakane M, Yoshizawa T et al (2013) Tanycytic ependymoma of the filum terminale associated with multiple endocrine neoplasia 1: first reported case. Spine J 13:e49–e54
Giraud S, Choplin H, Teh BT et al (1997) A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation. J Clin Endocrinol Metab 82:3487–3492
Kato H, Uchimura I, Morohoshi M et al (1996) Multiple endocrine neoplasia type 1 associated with spinal ependymoma. Intern Med 35:285–289
Kline CN, Joseph NM, Grenert JP et al (2016) Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro-Oncol [Epub Nov 14]
Pajtler KW, Witt H, Sill M et al (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27:728–743
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by NIH Director’s Early Independence Award (DP5 OD021403) to D.A.S.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Cuevas-Ocampo, A.K., Bollen, A.W., Goode, B. et al. Genetic confirmation that ependymoma can arise as part of multiple endocrine neoplasia type 1 (MEN1) syndrome. Acta Neuropathol 133, 661–663 (2017). https://doi.org/10.1007/s00401-017-1689-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-017-1689-7